Parcom Capital – Acquisition of Viroclinics Biosciences

4 septiembre, 2017

Parcom Capital, private equity firm focused in The Netherlands, has announced the acquisition of Viroclinics Biosciences from Gilde Healthcare Service. Financial details of the transaction have not been disclosed. Based in Rotterdam, Netherlands, Viroclinics is a CRO specialized in testing new vaccines and drugs in the clinical trial stages prior to market launch.